Alexander Mayweg is a Managing Director at Versant Ventures, where he focuses on biotech company creation around breakthrough discoveries and technologies. He invests across biotechnology, life sciences, medical, and therapeutics sectors at early through Series C stages, with activity in Europe, the United States, Asia, and Switzerland. He serves on the boards of Bright Peak Therapeutics, SixPeaks Bio, Red Ridge Bio, Serac Therapeutics, and Revelio Therapeutics, and has invested in companies like Bright Peak Therapeutics, Monte Rosa Therapeutics, Enterprise Therapeutics, SixPeaks Bio, and Red Ridge Bio. Before his current role, he was a Partner, Venture Partner, and Entrepreneur in Residence at Versant Ventures, and President and CSO at Ridgeline Therapeutics. Alexander graduated from the University of Oxford and lives in Basel, Switzerland.
Alexander Mayweg, Managing Director @ Versant. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Alexander Mayweg from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Alexander
Map your path to Alexander instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Alexander
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.